Evidence map›Paper›PMID 32731530›Full record

Trial reportInternational journal of molecular sciences2020

Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors.

Gabriella Dobra, Matyas Bukva, Zoltan Szabo, Bella Bruszel, Maria Harmati, Edina Gyukity-Sebestyen, Adrienn Jenei, Monika Szucs, Peter Horvath, Tamas Biro and 2 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Gabriella DobraLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
Matyas BukvaLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
Zoltan SzaboDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0001-8278-8038
Bella BruszelDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary.
Maria HarmatiLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.ORCID 0000-0002-4875-5723
Edina Gyukity-SebestyenLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
Adrienn JeneiDepartment of Neurosurgery, Clinical Centre, University of Debrecen, H-4032 Debrecen, Hungary.
Monika SzucsDepartment of Medical Physics and Informatics, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary.
Peter HorvathLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
Tamas BiroDepartment of Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Almos KleknerDepartment of Neurosurgery, Clinical Centre, University of Debrecen, H-4032 Debrecen, Hungary.
Krisztina BuzasLaboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUUniversity of Debrecen · HU

Funding

Hungarian Acedemy of Sciences Janos Bolyai Research ScholarshipMinistry for Innovation and Technology UNKP-19-4-SZTE-63Ministry of Finance, Hungary GINOP-2.2.1-15-2017-00052Ministry of Finance, Hungary GINOP-2.3.2-15-2016-00015NRDIO 2017-1.2.1-NKP-2017-00002
6 · The paper itself

Abstract

Liquid biopsy-based methods to test biomarkers (e.g., serum proteins and extracellular vesicles) may help to monitor brain tumors. In this proteomics-based study, we aimed to identify a characteristic protein fingerprint associated with central nervous system (CNS) tumors. Overall, 96 human serum samples were obtained from four patient groups, namely glioblastoma multiforme (GBM), non-small-cell lung cancer brain metastasis (BM), meningioma (M) and lumbar disc hernia patients (CTRL). After the isolation and characterization of small extracellular vesicles (sEVs) by nanoparticle tracking analysis (NTA) and atomic force microscopy (AFM), liquid chromatography -mass spectrometry (LC-MS) was performed on two different sample types (whole serum and serum sEVs). Statistical analyses (ratio, Cohen's d, receiver operating characteristic; ROC) were carried out to compare patient groups. To recognize differences between the two sample types, pairwise comparisons (Welch's test) and ingenuity pathway analysis (IPA) were performed. According to our knowledge, this is the first study that compares the proteome of whole serum and serum-derived sEVs. From the 311 proteins identified, 10 whole serum proteins and 17 sEV proteins showed the highest intergroup differences. Sixty-five proteins were significantly enriched in sEV samples, while 129 proteins were significantly depleted compared to whole serum. Based on principal component analysis (PCA) analyses, sEVs are more suitable to discriminate between the patient groups. Our results support that sEVs have greater potential to monitor CNS tumors, than whole serum.

Indexed as

Meningeal NeoplasmsAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Non-Small-Cell LungExtracellular VesiclesFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm ProteinsBiomarkers, TumorNeoplasm Proteinscancer biomarkerextracellular vesiclesproteomics

Identifiers

PMID32731530
PMCPMC7432723
OpenAlexW3046091296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.